Related Experiment Video
Updated: Jul 18, 2026

Y-27632 Enriches the Yield of Human Melanocytes from Adult Skin Tissues
Published on: July 8, 2020
A novel micronutrient supplement in skin aging: a randomized placebo-controlled double-blind study
1Skin Testing Department, Intercosmetica Neuchâtel SA, Neuchâtel, Switzerland. alain.beguin@intercosmetica.ch
Background:
Skin aging, a combination of intrinsic and environmentally induced processes, predominantly ultraviolet (UV) light from the sun, results in characteristic tissue alterations, such as the degradation of collagen and the formation of visible fine lines and wrinkles.
Objective:
To test the efficacy and safety of a novel micronutrient supplement (Estime) in skin aging.
Methods:
A 4-month randomized double-blind controlled study including 40 subjects where the supplement was tested against placebo for 3 months followed by a 1-month supplement-free period for both groups to assess lasting effects. Efficacy measurements included skin surface evaluation, ultrasound measurement of sun-exposed and protected areas of the skin (back of the hand and ventral forearms, respectively), and photographic assessment.
Results:
All investigated parameters showed a continuous and significant improvement in the active group during the 3 months of supplementation as compared to placebo. Photographs showed visible improvement of the overall skin appearance and reduction of fine lines. Ultrasound measurements showed an increase in dermis density of up to 78% in the active group (P < 0.0001). The final assessment after 1 month without supplementation showed no further improvements, but a slight decrease was observed in most improved parameters. No treatment-related side effects were reported.
Conclusion:
The study demonstrated that the supplement appears to be effective and safe as an oral supplement to protect the skin and support its repair process. Recommendations are made for further evaluations.
Insights
A novel micronutrient supplement (Estime) significantly improved skin aging signs like wrinkles and skin appearance in a 4-month study. This oral supplement demonstrated safety and efficacy in protecting and repairing skin, with lasting benefits observed.
Area of Science:
- Dermatology and Nutritional Science
- Skin Health and Aging Research
Background:
- Skin aging results from intrinsic factors and environmental damage, primarily UV radiation.
- This process leads to collagen degradation, fine lines, and wrinkles.
Purpose of the Study:
- To evaluate the efficacy and safety of a new oral micronutrient supplement, Estime, for mitigating skin aging.
- To assess the supplement's impact on skin structure and appearance.
Main Methods:
- A 4-month randomized, double-blind, placebo-controlled study involving 40 participants.
- Efficacy was measured through skin surface evaluation, ultrasound imaging of dermal density, and photographic analysis over 3 months of supplementation and a 1-month follow-up.
Main Results:
- The Estime group showed continuous and significant improvements in all measured skin parameters compared to placebo.
- Visible enhancements in overall skin appearance and reduction in fine lines were noted.
- Ultrasound revealed up to a 78% increase in dermal density (P < 0.0001) in the active group.
Conclusions:
- Estime is an effective and safe oral supplement for skin protection and repair, combating signs of aging.
- Further research is recommended to explore its long-term benefits and applications.
Related Concept Videos
Role of Skin in Vitamin D Synthesis
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin D3(cholecalciferol).
Renewal of Skin Epidermal Stem Cells
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
The Effect of Aging on Tissues
Tissue Renewal without Stem Cells
However, failure of such a system...
Bioavailability Study Design: Healthy Subjects Versus Patients